Boston Center for Memory

What Boston Center for Memory does

Boston Center for Memory (BCM) is a private, for-profit specialty healthcare practice headquartered in Newton, Massachusetts, founded in 2012 by clinical neuropsychologist Dr. Paul R. Solomon and Dr. Elizabeth A. Vassey. The clinic focuses on the diagnosis, treatment, and longitudinal care of patients with mild cognitive impairment (MCI), Alzheimer's disease, and related dementias, serving patients who are primarily located across the New England region (Massachusetts, Cape Cod, Maine, New Hampshire, Vermont, Rhode Island, and New York). Core services include free community memory screenings, full diagnostic and clinical care, and active participation as a clinical trial site for investigational Alzheimer's therapies.

BCM's clinical infrastructure is built around the founders' expertise: the practice reports 300+ publications, 40,000+ patient encounters, and involvement in 200+ clinical trials, and was one of the top global enrollers for the aducanumab program, the first FDA-approved disease-modifying Alzheimer's treatment in 2021. Operationally, BCM operates from a single Newton site with 11-50 staff, runs a psychiatrist-supplemented clinical model, and partners with the Boston University Alzheimer's Disease Center and the Alzheimer's Association MA/NH chapter. Its technical footprint is service-delivery rather than platform-based: assessments, neuropsychological testing, infusion visits for monoclonal antibody therapies, and trial data collection, with no disclosed proprietary software product.

BCM's revenue model is fee-for-service clinical care billed primarily to Medicare and private insurance, supplemented by per-patient reimbursement from pharmaceutical sponsors for clinical trial participation. Patient acquisition is multi-channel: free memory-screening events at community sites, YouTube and social media content, earned media, and inbound referrals coordinated through collaborative relationships with major Boston-area hospital systems. There is no disclosed external funding, and the practice appears to be founder-financed and bootstrapped.

Name

Boston Center for Memory

Legal name

Boston Center for Memory

Website

https://bostonmemory.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Boston Center for Memory is a Newton, Massachusetts specialty clinic founded in 2012 that diagnoses, treats, and runs clinical trials for patients with mild cognitive impairment, Alzheimer's disease, and related dementias across the New England region, with revenue from insurance billing and pharmaceutical sponsors.

Ownership category

akta.pro rank

Headquarters

HQ city

Newton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Services Revenue: Revenue generated from diagnostic evaluations, treatment services, and follow-up care billed to Medicare and private insurance providers.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Boston Center for Memory is a specialized outpatient healthcare center that diagnoses and treats memory disorders including Alzheimer's disease and dementia. Founded in 2012 and located at 180 Wells Avenue, Suite 304, Newton, MA 02459, the center provides memory screenings, comprehensive diagnostic and clinical care, follow-up care, and participation in clinical research trials for individuals experiencing cognitive decline.

Product overview

Boston Center for Memory is an independent multi-specialty diagnostic and treatment center offering three integrated service pillars: Memory Screens (free screening assessments), Diagnostic & Clinical Care (comprehensive evaluations with multi-specialty team approach), and Clinical Research Trials (Phase II/III trials for Alzheimer's treatments). The center provides complete care from screening through diagnosis, treatment planning, and ongoing follow-up care, working collaboratively with hospital systems in the greater Boston area.

Differentiator

Problem solved

Functional benefit

Products and services

• Memory Screens Standalone memory screening service offered to individuals who are concerned about cognitive changes; serves as an entry point for patients before full diagnostic workup.
• Diagnostic & Clinical Care Comprehensive diagnostic evaluation and clinical treatment services for patients diagnosed with memory disorders, including Alzheimer's disease and dementia.
• Clinical Research Trials Participation in clinical research trials for patients with memory disorders, providing access to investigational therapies and contributing to Alzheimer's and dementia research.
• Follow-up Care Ongoing follow-up care service for patients after diagnosis and initial treatment, supporting long-term management of memory disorders.

Quantifiable outcome

• First-ever disease modifying treatment (aducanumab) FDA-approved with BCM as one of the leading enrollers globally

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered core and minor.

• Alzheimer's Association MA/NH ChaptercoreStrategic or Co-development PartnerBCM clinicians and staff actively participate in Alzheimer's Association events including the Walk to End Alzheimer's, MAP through the Maze conferences, and educational programs. Dr. Vassey serves on the Medical & Scientific Liaison Committee. The partnership involves joint advocacy efforts and educational initiatives for Alzheimer's awareness and research funding.
• Boston University Alzheimer's Disease Center (BU ADC)coreStrategic or Co-development PartnerDr. Paul Solomon is an investigator at BU ADC and Dr. Elizabeth Vassey serves as an Assistant Professor of Neurology at Boston University School of Medicine and Investigator in the Clinical Core. Dr. Vassey completed her Postdoctoral Fellowship from the Department of Neurology at BU ADC. The center collaborates on research initiatives and clinical trials.
• Williams CollegeminorStrategic or Co-development PartnerDr. Solomon founded the neuroscience program at Williams College and serves as Professor Emeritus. Historical connection through academic position.
• Boonefield LabradorsminorOthersBreeder in Rindge, New Hampshire that provided Walter, BCM's therapy dog who joined the team in 2020 and became certified in December 2021.
• Greater Boston Hospital SystemscoreStrategic or Co-development PartnerBCM works collaboratively with all hospital systems in the greater Boston area for patient referrals and coordinated care.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Re:Cognition Health: UK-based specialty memory and cognition clinic network running commercial diagnostic evaluations and high-volume clinical trials in Alzheimer's/MCI. Closest international analog to BCM's independent, trial-driven specialty memory clinic model.
• Cleveland Clinic Lou Ruvo Center for Brain Health: Cleveland Clinic's specialty memory and cognition center operates a multi-specialty clinical and clinical-trial model very similar to BCM: cognitive neurology, neuropsychology, and clinical research in Alzheimer's/MCI. Like BCM, it functions as a high-enrolling trial site for disease-modifying therapies.
• Banner Alzheimer's Institute: Banner Alzheimer's Institute in Phoenix is a stand-alone specialty center that combines clinical diagnosis of MCI/Alzheimer's with one of the largest Alzheimer's prevention and treatment trial programs in the U.S. Closely comparable to BCM in mission, multi-specialty staffing, and trial-site-of-choice status.
• Mayo Clinic Alzheimer's Disease Research Center: Mayo's ADRC is a leading integrated clinical-research memory program offering specialty evaluation and Phase II/III trial enrollment. Same multi-specialty diagnostic-plus-research architecture as BCM, but embedded in a much larger health system.
• Keck Medicine of USC Memory and Aging Center: USC's Memory and Aging Center runs an academic multi-specialty clinic (neurology, psychiatry, neuropsychology) for MCI/Alzheimer's and is an active Alzheimer's clinical research site. Directly comparable service model to BCM at larger scale.

Others

• Cogstate: Cogstate provides computerized cognitive testing used as primary and secondary endpoints in Alzheimer's clinical trials. As a supplier adjacent to BCM's psychometric/rater work, it is ecosystem-relevant rather than a direct competitor.
• Biogen: Biogen developed aducanumab (the first FDA-approved disease-modifying Alzheimer's therapy) for which BCM was a leading enroller. They are a sponsor partner in BCM's clinical trial business, not a competitor, but their commercial anti-amyloid pipeline directly drives BCM's trial opportunities.

Broad incumbents

• BrightSpring Health Services: BrightSpring operates home and community health services including pharmacy, hospice, and behavioral health, with growing exposure to dementia and geriatric care. Broad incumbent rather than direct specialty memory competitor.
• Compassus: Compassus is a large post-acute and home-based care provider (hospice, home health, palliative) that increasingly touches dementia care. A broad incumbent adjacent to BCM's diagnosis-and-treatment arc but operating at scale across the care continuum.
• Acadia Healthcare: Acadia is a behavioral health services company operating inpatient psychiatric and specialty residential programs, including dementia/neuropsychiatric units. Comparable to BCM's geriatric psychiatry capability at scale and as a publicly traded peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCbMW0W2e72F1FRqnjW6z-Ew
• Facebookfacebook.com/bostonmemory
• LinkedInlinkedin.com/company/boston-center-for-memory
• Instagraminstagram.com/teambcm

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boston Center for Memory